Published in Arch Neurol on May 01, 1968
Guillain-Barré syndrome after myocardial infarction. Br Med J (Clin Res Ed) (1987) 0.91
Clinical aspects of Guillian-Barré syndrome: a review. J R Soc Med (1979) 0.88
Peripheral neuropathy complicating pancreatitis and major pancreatic surgery. J Neurol Neurosurg Psychiatry (1988) 0.76
Guillain-Barre Syndrome After Robotically Assisted Laparoscopic Prostatectomy: First Case Report. Urol Case Rep (2015) 0.75
Idiopathic polyneuritis. West J Med (1974) 0.75
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Induction of tumour immunity with tumour cells treated with iodoacetate. Nature (1966) 2.42
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci (1976) 2.20
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Glue-sniffing neuropathy. Arch Neurol (1975) 1.99
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Giant axonal neuropathy--a unique case with segmental neurofilamentous masses. Acta Neuropathol (1972) 1.91
Secretion of a nerve growth factor by primary chick fibroblast cultures. Science (1975) 1.88
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74
Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
The initial lesion in experimental allergic neuritis. A phase and electron microscopic study. J Exp Med (1968) 1.68
Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci U S A (1974) 1.64
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57
Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain (1975) 1.56
Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology (1995) 1.53
Giant axonal neuropathy. Pediatrics (1972) 1.53
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51
Sensory perineuritis. Arch Neurol (1972) 1.51
Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 1.49
The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol (1980) 1.47
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol (1991) 1.46
Diabetic neuropathy. Ann Neurol (1984) 1.44
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study. J Cell Biol (1967) 1.41
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Multiple sclerosis: additional thoughts. J Neurol Sci (1992) 1.38
Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med (1976) 1.36
Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc Natl Acad Sci U S A (1975) 1.36
S-100 protein in human chondrocytes. Nature (1982) 1.35
Interferon beta in multiple sclerosis. Neurology (1993) 1.35
Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol (1970) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Studies on the mechanism of action of nerve growth factor. Proc Natl Acad Sci U S A (1972) 1.32
Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32
Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol (1974) 1.31
Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature (1980) 1.28
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest (1969) 1.28
Experimental autonomic neuropathy: an immunologically induced disorder of reflex vasomotor function. J Neurol Neurosurg Psychiatry (1965) 1.26
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25
Suppressor cell function in multiple sclerosis. Ann Immunol (Paris) (1978) 1.22
Hereditary sensory neuropathy. A clinical and ultrastructural study. J Neurol Sci (1970) 1.22
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Distal neuropathy in experimental diabetes mellitus. Ann Neurol (1980) 1.15
Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference. Neurology (1996) 1.15
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Renaut bodies. A forgotten endoneurial structure. J Neuropathol Exp Neurol (1973) 1.14
Pain due to peripheral nerve damage: an hypothesis. Neurology (1984) 1.14
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol (1981) 1.08
Cell-mediated immunity in polymyositis. Creatine phosphokinase release from muscle cultures. Arch Neurol (1974) 1.07
The significance of giant vacuolation of endoneurial fibroblasts. Acta Neuropathol (1971) 1.05
A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes. Nature (1982) 1.05
Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci (1974) 1.05
Monoclonal antibodies against purified nicotinic acetylcholine receptor. Biochem Biophys Res Commun (1979) 1.04
Intra-axonal bacilli in lepromatous leprosy. A light and electron microscopic study. Acta Neuropathol (1974) 1.04
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Comparison of clinical couse and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes (1981) 1.04
Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack. Brain (1970) 1.03
Pupil-involving third-nerve palsy and carotid stenosis: rapid recovery following endarterectomy. Ann Neurol (1997) 1.02
In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol (1982) 1.02
Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol (1969) 1.01
Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol (1993) 1.01
Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol (1982) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
A study of B and T cells in multiple sclerosis. Neurology (1975) 0.99
Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J Infect Dis (1999) 0.99
Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes. Proc Natl Acad Sci U S A (1979) 0.99
Patterns of recovery in the Guillain-Barre syndromes. Neurology (1997) 0.99
Proximal diabetic neuropathy. Ann Neurol (1977) 0.99
Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med (1980) 0.99
Neuropathologic effects of proton-beam irradiation in man. I. Dose-response relationships after treatment of intracranial neoplasms. Acta Neuropathol (1972) 0.97
EAN as a model for idiopathic polyneuritis. Trans Am Neurol Assoc (1968) 0.96
Schwann cell proliferation in the postnatal mouse: timing and topography. Exp Neurol (1981) 0.96
The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol Scand (1968) 0.96
Idiopathic polyneuritis (Landry-Guillain-Barré-Strohl syndrome) and experimental allergic neuritis: a comparison. Res Publ Assoc Res Nerv Ment Dis (1971) 0.95
Cell-mediated immunity in idiopathic polyneuritis. Ann Neurol (1981) 0.95
Secretion of nerve growth factor by central nervous system glioma cells in culture. J Cell Biol (1977) 0.95
Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology (1996) 0.94